| Name of agent |
Format |
| Electrophoresis |
Flash |
Rt |
qPCR |
| Hepatitis |
| Hepatitis virus B (HBV) |
* |
* |
* |
* |
| Hepatitis A virus (HAV) |
* |
* |
|
|
| Hepatitis C virus (HCV) |
* |
* |
* |
* |
| Hepatitis B virus D (HDV) |
* |
* |
|
|
| Hepatitis B virus G (HGV) |
* |
|
|
|
| Genotyping of HCV |
* |
|
* |
|
| Human immunodeficiency virus |
| Human immunodeficiency virus, HIV (HIV) |
* |
* |
* |
* |
| Urogenital infections |
| Chlamydia trachomatis (Chlamydia trachomatis) |
* |
* |
* |
|
| Mycoplasma hominis (Mycoplasma hominis) |
* |
* |
* |
|
| Mycoplasma genitalium (Mycoplasma genitalium) |
* |
* |
* |
|
| Ureaplasma (Ureaplasma urealyticum + parvum) |
* |
* |
* |
|
| Ureaplasma parvum (Ureaplasma parvum) |
* |
* |
* |
|
| Ureaplasma urealitikum (Ureaplasma urealyticum) |
* |
* |
* |
|
| Trihomonas vaginalis (Trichomonas vaginalis) |
* |
* |
* |
|
| Gardnerella vaginalis (Gardnerella vaginalis) |
* |
* |
* |
|
| Neisseria gonorrhea (Neisseria gonorrhoeae) |
* |
* |
* |
|
| Albikans Candida (Candida albicans ) |
* |
* |
* |
|
| Herpes virus infection |
| Herpes simplex virus 1,2 (HSV 1,2) |
* |
* |
* |
|
| Human herpes virus type 6 (HHV 6) |
* |
* |
* |
|
| Human herpes virus type 8 (HHV 8) |
* |
* |
* |
|
| Cytomegalovirus (Sytomegalovirus) |
* |
* |
* |
|
| Human papillomavirus infection |
| Human papilloma virus, HPV [16, 18] |
* |
* |
* |
|
| Human papillomavirus high-oncogenic risk HPV (16,31,35); (33,52,58); (18,39,45,59) |
|
|
* |
|
| Human papilloma virus, HPV (16, 31, 33, 35, 35H, 58, 52, 67) |
* |
|
|
|
| Human papilloma virus, HPV (18, 45, 39, 59) |
* |
|
|
|
| Human papilloma virus, HPV (51,26) |
* |
|
|
|
| Human papilloma virus, HPV (6, 11) |
* |
|
|
|
| Study biocenosis urogenital tract |
| A set of reagents for research biocenosis Femoflor 4 |
|
|
|
* |
| A set of reagents for research biocenosis Femoflor 8 |
|
|
|
* |
| A set of reagents for research biocenosis Femoflor 16 |
|
|
|
* |
| FEMOFLOR-Screen kit for screening studies of urogenital tract microflora in women |
|
|
|
* |
| Respiratory tract infections |
| Mycobacterium tuberculosis Mycobacterium tuberculosis - Mycobacterium bovis complex) |
* |
* |
* |
|
| Chlamydia pneumonia (Chlamydia pneumonia ) |
* |
|
|
|
| Mycobacterium tuberculosis (M. tuberculosis) |
* |
|
|
|
| Bordetella pertussis (Bordetella pertussis) |
* |
* |
* |
|
| Toxigenic strains of Corynebacterium diphtheria |
* |
* |
* |
|
| Hemolytic streptococcus (Streptococcus pyogenes) |
* |
* |
* |
|
| Pnevmofila Legionella (Legionella pneumophila) |
* |
* |
* |
|
| Influenza A virus strain H5N1 (bird flu) |
|
* |
* |
|
| Influenza A virus strain H1N1 (swine flu) |
|
|
* |
|
| Influenza A virus |
|
|
* |
|
| Particularly dangerous and natural foci of infection |
| Borrelia burgdorferi (Borrelia burgdorferi) |
|
* |
* |
|
| Toxigenic strains of Vibrio cholerae (Vibrio cholerae) |
|
* |
* |
|
| Anthrax (Bacillus anthracis) |
|
* |
* |
|
| Plague (Yersinia pestis) |
|
* |
* |
|
| Tularemia (Francisella tularensis) |
|
* |
|
|
| Kit for detection of GMO |
| SCAN-Soy |
|
* |
* |
|
| SCAN-Corn |
|
* |
* |
|
| Flank gene (35S promoter and terminator NOS) |
|
* |
* |
|
| Promoter - GM maize (promoter 35S) |
* |
* |
* |
|
| Promoter - GM Soybean (promoter 35S) |
* |
* |
* |
|
| Terminator - GM Soybean (Terminator NOS) |
|
|
* |
|
| Terminator - The GM maize (Terminator NOS) |
|
|
* |
|
| Terminator - The GM potato (Terminator NOS) |
|
|
* |
|
| Maize line MON 810 |
|
* |
* |
|
| Quantum II - Soybean (promoter 35S) |
|
|
|
* |
| Quantum II - Maize (promoter 35S) |
|
|
|
* |
| Human Genetics |
| HLA-DR B1 |
* |
|
|
|
| HLA-DQ A1 |
* |
|
|
|
| HLA-DQ B1 |
* |
|
|
|
| KardioGenetika Hypertension |
|
|
* |
|
| KardioGenetika Thrombophilia |
|
|
* |
|
| Genetics Metabolism of folate |
|
|
* |
|
| Warfarin Pharmacogenetics |
|
|
* |
|
| Oncogenetics BRCA |
|
|
* |
|
| KVM kit for taking control of the material |
|
|
|
* |